Literature DB >> 24608546

Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project.

Michael P Boyle1, Kathryn A Sabadosa, Hebe B Quinton, Bruce C Marshall, Michael S Schechter.   

Abstract

Benchmarking is the process of using outcome data to identify high-performing centres and determine practices associated with their outstanding performance. The US Cystic Fibrosis Foundation (CFF) Patient Registry contains centre-specific outcomes data for all CFF-certified paediatric and adult cystic fibrosis (CF) care programmes in the USA. The CFF benchmarking project analysed these registry data, adjusting for differences in patient case mix known to influence outcomes, and identified the top-performing US paediatric and adult CF care programmes for pulmonary and nutritional outcomes. Separate multidisciplinary paediatric and adult benchmarking teams each visited 10 CF care programmes, five in the top quintile for pulmonary outcomes and five in the top quintile for nutritional outcomes. Key practice patterns and approaches present in both paediatric and adult programmes with outstanding clinical outcomes were identified and could be summarised as systems, attitudes, practices, patient/family empowerment and projects. These included: (1) the presence of strong leadership and a well-functioning care team working with a systematic approach to providing consistent care; (2) high expectations for outcomes among providers and families; (3) early and aggressive management of clinical declines, avoiding reliance on 'rescues'; and (4) patients/families that were engaged, empowered and well informed on disease management and its rationale. In summary, assessment of practice patterns at CF care centres with top-quintile pulmonary and nutritional outcomes provides insight into characteristic practices that may aid in optimising patient outcomes.

Entities:  

Keywords:  Attitudes; Chronic Disease Management; Healthcare Quality Improvement

Mesh:

Year:  2014        PMID: 24608546     DOI: 10.1136/bmjqs-2013-002369

Source DB:  PubMed          Journal:  BMJ Qual Saf        ISSN: 2044-5415            Impact factor:   7.035


  14 in total

1.  Socioeconomic Status, Smoke Exposure, and Health Outcomes in Young Children With Cystic Fibrosis.

Authors:  Thida Ong; Michael Schechter; Jing Yang; Limin Peng; Julia Emerson; Ronald L Gibson; Wayne Morgan; Margaret Rosenfeld
Journal:  Pediatrics       Date:  2017-01-16       Impact factor: 7.124

2.  Impact of guideline-recommended dietitian assessments on weight gain in infants with cystic fibrosis.

Authors:  Thida Ong; Frankline M Onchiri; Maria T Britto; Sonya L Heltshe; Larry G Kessler; Michael Seid; Bonnie W Ramsey
Journal:  J Cyst Fibros       Date:  2021-08-26       Impact factor: 5.482

3.  Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.

Authors:  Don B Sanders; Julia Emerson; Clement L Ren; Michael S Schechter; Ronald L Gibson; Wayne Morgan; Margaret Rosenfeld
Journal:  Ann Am Thorac Soc       Date:  2015-08

Review 4.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

5.  Highlights from the 2015 North American Cystic Fibrosis Conference.

Authors:  Edith T Zemanick; Thida Ong; Cori L Daines; Elisabeth P Dellon; Marianne S Muhlebach; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2016-04-13

Review 6.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

7.  Does current reporting of lung function by the UK cystic fibrosis registry allow a fair comparison of adult centres?

Authors:  Julia Anne Nightingale; Clive Osmond
Journal:  J Cyst Fibros       Date:  2017-04-24       Impact factor: 5.482

8.  Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States.

Authors:  Christopher H Goss; Jenna Sykes; Sanja Stanojevic; Bruce Marshall; Kristofer Petren; Josh Ostrenga; Aliza Fink; Alexander Elbert; Bradley S Quon; Anne L Stephenson
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 30.528

9.  Effect of Named, Accountable GPs on Continuity of Care: Protocol for a Regression Discontinuity Study of a National Policy Change.

Authors:  Therese Lloyd; Adam Steventon
Journal:  Int J Integr Care       Date:  2016-03-31       Impact factor: 5.120

10.  Using different methods to process forced expiratory volume in one second (FEV 1) data can impact on the interpretation of FEV 1 as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart review.

Authors:  Zhe Hui Hoo; Muhaned S A El-Gheryani; Rachael Curley; Martin J Wildman
Journal:  F1000Res       Date:  2018-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.